Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Stromal Tumours of Uncertain Malignant Potential (STUMP) (CROSBI ID 683537)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Štifter, Sanja ; Barbazza, Renzo ; Cescato, Alberto ; Đorđevic, Gordana. ; Gašparić, Sandra Stromal Tumours of Uncertain Malignant Potential (STUMP) // Virchows archiv. 2019. str. 424-424

Podaci o odgovornosti

Štifter, Sanja ; Barbazza, Renzo ; Cescato, Alberto ; Đorđevic, Gordana. ; Gašparić, Sandra

engleski

Stromal Tumours of Uncertain Malignant Potential (STUMP)

Background & Objectives: Prostatic Stromal Tumours of Uncertain Malignant Potential (STUMP) are non-epithelial mesenchymal spindlecell origin prostate tumours classified as a specialized stromal tumour of the prostate. They represent rare neoplastic proliferative lesions that according to WHO classification together with prostatic stromal sarcoma (SS) comprise up to 0.2% of all malignant prostate tumours. Methods: We present a case of patient clinically presented with symptoms of acute urinary retention (AUR). Digital rectal examination (DRE) showed the presence of a pronounced prostatic hyperplasia and a transurethral prostatic adenomectomy (TURPA) was performed. The primary pathological evaluation was performed at Laboratorii Uniti, Italy and second opinion at the Department of Pathology, Clinical Hospital Centre Rijeka, Croatia upon an incidental and unexpected diagnosis of prostatic STUMP. It was morphologically discriminated based on following criteria: stromal cellularity, presence of occasional mitotic figures, necrosis, and stromal overgrowth. Thorough immunohistochemistry evaluation and tumour immunophenotyping was performed. Results: Presented tumour was immunohistochemically positive for CD34, Vimentin, progesterone and cytokeratin negative. It diffusely infiltrated the prostate gland and extend into adjacent tissues. Mitotic count was low, while focally marked cellular atypia was observed throughout the lesion. The capacity of recurrence placed it into the group considered to have frank neoplastic capacity. Therefore the clinical and further therapeutic management should be made keeping in mind the probability of progression into sarcoma. Conclusion: Currently, due to a small number of cases and consequent follow up the recommended treatment algorithm does not exist. According to some authors and literature data, radical prostatectomy seem to be the treatment of choice, especially in young patient or for extensive recurrent lesion. The presented case stresses out the need for extensive sampling in order to fully appreciate tumour heterogeneity, because STUMP remains diagnosis by exclusion.

stromal tumours

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

424-424.

2019.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Virchows archiv

0945-6317

1432-2307

Podaci o skupu

31st European Congress of Pathology

poster

07.09.2019-11.09.2019

Nica, Francuska

Povezanost rada

Temeljne medicinske znanosti